Recommendations for clinical decision-making when offering exoskeletons for community use in individuals with spinal cord injury
{{output}}
Approved in 2014 by the Food and Drug Administration (FDA) for use with a trained companion, personal powered exoskeletons (PPE) for individuals with spinal cord injury (SCI) provide an opportunity for the appropriate candidate to ambulate in their home and co... ...
